BEBassel Elzorkany

Bassel Elzorkany

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Bassel Elzorkany has a total of 316 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clinical phenotype, disease burden and inter-regional heterogeneity of axial spondyloarthritis in 1112 patients across 15 Arab countries: the PROSPA study

    by Nelly Ziade, Farid Abou Abdallah, Riwa Kfoury, Rawdha Tekaya, Avin Maroof, Fatma Zohra Yasmina Heddi, Krystel Aouad, Sahar Saad, Suad Hannawi, Chafia Makhloufi-Dahou, et al.

    Objectives To characterise the phenotype, disease burden, comorbidities, patient-reported outcomes (PROs) and treatment patterns of axial spondyloarthritis (axSpA) across Arab countries and evaluate regional heterogeneity.Methods Profile of Axial Spondyloarthritis in Arab Countries (PROSPA), a cross-sectional, multinational study by the ArLAR Research Group across 33 rheumatology centres in 15 countries, enrolled adults with axSpA during a routine visit. Standardised data on validated PROs, disease characteristics, comorbidities and treatment were collected. Patients were stratified by Arab subregion (North Africa, the Levant and the Gulf). Between-group comparisons used Welch analysis of variance, Kruskal-Wallis and χ 2 tests. Mixed-effects modelling tested whether regional differences in Assessment of SpondyloArthritis international Society Health Index (ASAS-HI) remained independent after adjustment.Results Of 1112 patients (mean age 42.6 years, median disease duration 10 years, 63.8% male), radiographic (r) predominated over non-radiographic (nr) axSpA (r/nr ratio 3.7). Peripheral arthritis occurred in 45.7%, coxitis in 31.7%, uveitis in 16.7% and psoriasis in 17.4%. Human leucocyte antigen B27 was positive in 51.5% of 615 tested. Disease activity was moderate to high; biologic disease-modifying antirheumatic drugs (bDMARDs) were used in 70.1%, 36.4% were people who smoke and 5.2% had a tuberculosis history. North Africa had the highest r/nr ratio, worst PROs and lowest bDMARD use, despite comparable disease activity. Regional differences in ASAS-HI did not persist after adjustment; disease activity and function accounted for most explained variance.Conclusions This largest multinational axSpA study revealed a predominantly radiographic phenotype, significant disease burden and a comorbidity profile marked by high smoking and tuberculosis rates. After adjustment, region was not independently associated with ASAS-HI; disease activity and function, rather than geography, explained most of the variance in health status.

  • Open Access

    Rheumatic Diseases in Egypt

    by Lobna A. Maged, Kamal El-Garf, Mervat Eissa, Walaa Abdelrahman, Bassel El Zorkany

    Egypt is one of the oldest civilizations in the world and the most populous Arab country, with an estimated population of 103 million people in 2022. Despite a free healthcare services policy, the healthcare system in Egypt faces some challenges, including a low level of government health expenditure (4–5% of gross domestic product, GDP) with a resultant high out-of-pocket expenditure (57.2% of total health expenditure). Although there are no formal screening programs for rheumatic diseases in Egypt, the estimated burden of rheumatic diseases was 0.04% of the total disease burden in Egypt in 2014. The laboratory and radiological investigations necessary for diagnosing rheumatic diseases, as well as the facilities required for their proper management, pose minor obstacles. Economic and financial constraints, however, present a significant challenge to ensuring equity in provided services. There are ongoing attempts to improve insurance coverage to face such challenges. With around 1200 rheumatologists and some rheumatology associations, including the Egyptian Society of Rheumatic Diseases, Egypt has an active pivotal role in research and managing rheumatic diseases in the Arab world.

  • Do the Psoriatic Arthritis Impact of Disease’s cutoffs vary across ethnicities? Insights from the TACTIC initiative

    by Wafa Hamdi, Hanene Lassoued Ferjani, Noura Abbas, Laure Gossec, Ihsane Hmamouchi, Fatima Alnaimat, Krystel Aouad, Avin Maarouf, Suad Hannawi, Chafika Haouichat, et al.

    Objective To establish cutoff values for the Arabic version of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire and examine their applicability across different cultural and ethnic backgrounds in Arab countries. Methods This study is a sub-analysis of the TACTIC initiative, a multicentric, multinational cross-sectional study. A total of 553 patients diagnosed with PsA from 13 Arab countries were included. Demographic and clinical data were collected, and disease activity was assessed using the Disease Activity in Psoriatic Arthritis (DAPSA) score. Psychometric scores, including the Patient Global Assessment (PGA), Health Assessment Questionnaire (HAQ), Patient Health Questionnaire (PHQ-4), and Fibromyalgia Screening Tool (FiRST), were also evaluated. PsAID thresholds were determined using Ward’s method and the “Anchor-based Threshold Determination” according to changes in DAPSA categories. Results Five hundred fifty-three patients were included in the current analysis, with 59.0% being female. The mean age of the patients was 45.5 years (SD 13.15), and the mean disease duration was 8.8 years (SD 7.3). The mean PsAID was 3.8 (SD 2.3), and the mean DAPSA was 19.3 (SD 16.1). Two clusters were identified based on PsAID levels. Cluster 1 (n = 315) had a mean PsAID of 2.15, while cluster 2 (n = 238) had a mean PsAID of 6.12. Using Ward’s method, the cutoff value was established at 4.1. A strong positive correlation was observed between DAPSA and PsAID scores (r = 0.718, p < 0.001). The anchor-based threshold analysis—based on shifts in DAPSA disease activity categories—identified a cutoff value of 3.8, which demonstrated good sensitivity and specificity in distinguishing between different levels of disease activity with an AUC of 0.83. Conclusion The Arabic PsAID threshold was found to be consistent with the internationally established value of 4. These identified cutoff points can serve as valuable tools for evaluating the impact of psoriatic arthritis on patients' quality of life. Moreover, they can help guide more personalized treatment strategies across diverse populations and ethnic groups. Key Points • This study established cutoff values for the Arabic version of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, confirming their alignment with international thresholds. • Analysis of 553 patients from 13 Arab countries demonstrated robust correlations between PsAID and disease activity measures, with an optimal cutoff around 4. • These thresholds provide reliable tools for assessing disease impact and can support personalized treatment strategies across diverse Arab populations.

  • Impact of concomitant fibromyalgia on patient-reported outcomes and inflammatory markers in psoriatic arthritis: a multinational cross-sectional study

    by Avin Maroof, Nelly Ziadé, Noura Abbas, Laure Gossec, Lina El Kibbi, Bassel Elzorkany, Nizar Abdulateef Jassim, Faiq I. Gorial, Asal Adnan, Nada Al Shamaa, et al.


  • Global patterns and determinants of diagnostic delay in spondyloarthritis: insights from the ASAS-PerSpA international study

    by Maroun Aoun, Sherif M Gamal, Ihsane Hmamouchi, Clementina Lopez-Medina, Maxime Dougados, Bassel Elzorkany, Nelly Ziade

    Objectives: Diagnostic delay (DD) is well-documented in SpA, particularly in axial disease. This ancillary analysis from the ASAS-PerSpA study estimated DD across SpA entities, considering the presenting disease manifestation, and evaluated factors associated with DD. Methods: This study included 4339 patients with any SpA entity (axial (axSpA), peripheral (pSpA), PsA, inflammatory bowel disease-associated SpA (IBD-SpA), ReA and juvenile SpA). DD was assessed using two definitions: (1) the first included extra-musculoskeletal manifestation (EMM) if any, as possible initial symptom, and (2) the second considered strictly the first musculoskeletal manifestation (MM) as the disease onset. DD was statistically compared across disease entities, and associated factors were evaluated using multivariable linear regression models for axSpA, PsA, pSpA and IBD-SpA. Results: The analysis included 2622 axSpA, 1016 PsA, 424 pSpA, 110 IBD-SpA, and 167 other SpA patients. The average DD was shorter using definition 2 (4.5 ± 7.0 vs 6.6 ± 8.6 years). Based on definition 2, DD was longer for axSpA and IBD-SpA (5.6 ± 7.3 and 5.2 ± 7.7 years, respectively), where the first MM was axial, compared with PsA (2.5 ± 6.1 years), pSpA (3.1 ± 5.9 years) and others, where it was peripheral (P < 0.001). Axial first manifestation, younger age at first symptom and older age at study inclusion were associated with longer DD in the four SpA entities. Conclusion: DD was longer in axSpA and IBD-SpA compared with PsA, pSpA and other forms of SpA and associated with the phenotype of the presenting symptom. SpA entities and presenting symptoms should be considered when reporting DD in SpA.


  • Discordance between patient and physician global assessments of psoriatic arthritis activity: an observational study in 13 Arab countries

    by Noura Abbas, Ihsane Hmamouchi, Lina El Kibbi, Avin Maroof, Bassel Elzorkany, Nizar Abdulateef, Asal Adnan, Nabaa Ihsan, Faiq Isho Gorial, Nada Al Chama, et al.

    Discordance between physicians and patients in assessing psoriatic arthritis (PsA) activity is common and might impact treatment adherence and decision-making. Cultural and belief systems may influence this discordance. This study aimed to assess the extent of patient-physician discordance in PsA in Arab countries and its association with demographic and disease characteristics.The TACTIC study was a cross-sectional observational study across 13 Arab countries in 2022. Patient and physician global assessments (PGA, PhGA) of disease activity (0–10 scale) were collected, along with demographic and disease data, Disease Activity in Psoriatic Arthritis (DAPSA), and Psoriatic Arthritis Impact of Disease (PsAID). Discordance was defined as an absolute difference of |PGA-PhGA|> 2. Its association with patient characteristics was analyzed through multivariable multinomial logistic regression. In 538 patients (317 females, 58.9%), with a mean age of 45.5 ± 13.2 years and PsA duration of 8.8 ± 7.3 years, the disease was moderately active (mean DAPSA 19.3 ± 16.1; mean PsAID 3.86 ± 2.33). Mean PGA was higher than mean PhGA (4.7 ± 2.5 versus 4.0 ± 2.4, p < 0.001) with an absolute difference of 1.30 ± 1.41 and a high correlation between global assessments (r = 0.74). Discordance was infrequent, occurring in 84 patients (15.6%), and was mostly due to higher PGA (70/84, 83.3%). Discordance (one-point increase) was associated with a lower PhGA (Odds ratio (OR) 3.03 [95%CI 2.18–4.22]), positive fibromyalgia screening (OR 1.28 [95%CI 1.03–1.58]), higher DAPSA (OR 1.16 [95%CI 1.03–1.09]), and higher PsAID scores (OR 2.63 [95%CI 1.96–3.54]). Discordance was primarily identified in patients with moderate disease activity. Discordance between PGA and PhGA was infrequent in Arab countries, suggesting strong patient-physician alignment. Expectations and disease perceptions may play a role in this discordance.


  • Top Cited Papers
    Open Access

    The Assessment of SpondyloArthritis International Society (ASAS) Consensus-Based Expert Definition of Difficult-to-Manage, including Treatment-Refractory, Axial Spondyloarthritis

    by Denis Poddubnyy, Victoria Navarro-Compán, Murat Torgutalp, Suzanne Arends, Sibel Zehra Aydin, Simone Battista, Filip van Den Bosch, Christine Bundy, Alberto Cauli, Jo Davies, et al.


  • Is the patient-perceived impact of psoriatic arthritis a global concept? An international study in 13 Arab countries (TACTIC study)

    by Nelly Ziadé, Noura Abbas, Ihsane Hmamouchi, Lina El Kibbi, Avin Maroof, Bassel Elzorkany, Nizar Abdulateef, Asal Adnan, Nabaa Ihsan Awadh, Faiq Isho Gorial, et al.

    The Psoriatic Arthritis Impact of Disease (PsAID-12) questionnaire, a recommended measure of patient-reported impact for psoriatic arthritis (PsA), was initially developed in Europe and may lack universal validity. Recognizing the need for a culturally appropriate tool for Arab patients, this study aimed to TranslAte, CulTurally adapt, and validate the PsAID in ArabIC (TACTIC). The PsAID-12 was translated into Arabic using a rigorous process of double translation, back-translation, and cognitive debriefing. The Arabic version was then validated through a study conducted in 13 Arab countries in 2022. Participants were consecutive literate adult patients diagnosed with PsA and fulfilling the CASPAR criteria. Collected data included PsAID-12, disease activity, and legacy patient-reported outcomes. Psychometric properties, such as internal consistency, construct validity, and test–retest reliability, were examined. Factors associated with high PsAID-12 total scores (> 4) were explored using multivariable binary logistic regression. A culturally adapted Arabic PsAID-12 questionnaire was achieved with minor rephrasing. The validation study included 554 patients from 13 countries (mean age 45 years, 59% females), with a mean PsAID score of 3.86 (SD 2.33). The Arabic PsAID-12 demonstrated excellent internal consistency (Cronbach’s α = 0.95), and correlations with other measures ranged from 0.63 to 0.78. Test–retest reliability (N = 138 patients) was substantial (intraclass correlation coefficient, ICC 0.90 [0.86–0.93]; Cohen’s kappa 0.80). Factors associated with a high PsAID score were disability (odds ratio, OR 3.15 [2.03–4.89]), depression (OR 1.56 [1.35–1.81]), widespread pain (OR 1.31 [1.12–1.53]), and disease activity (OR 1.29 [1.13–1.47]). Pain and fatigue were identified as the most impactful PsAID-12 domains for PsA patients. The Arabic PsAID is a valid and reliable measure that reflects the priorities of patients with PsA. PsAID scores correlated with disease activity and legacy outcome measures, as expected, indicating PsAID is a consistent measure of PsA impact across cultures. These findings highlight the potential of the Arabic PsAID in improving the care provided to Arabic-speaking patients worldwide.


  • The rheumatology workforce in the Arab countries: current status, challenges, opportunities, and future needs from an ArLAR cross-sectional survey

    by Nelly Ziade, Ihsane Hmamouchi, Chafika Haouichat, Fatemah Baron, Sulaiman Al Mayouf, Nizar Abdulateef, Basel Masri, Manal El Rakawi, Lina El Kibbi, Manal El Mashaleh, et al.

    The Arab League of Associations for Rheumatology (ArLAR) Research Group (ARCH) conducted this study to investigate the number of current practicing rheumatologists in the Arab countries, to estimate the projected number of rheumatologists in 10 years, and to evaluate the current workload, practice profile, consultation waiting time, and geographical mobilities of these rheumatologists. This cross-sectional survey study was conducted in 16 Arab countries in two parts. The first survey was addressed nominally to national societies to estimate the current and projected workforce. The second was an anonymous e-survey elaborated by the study steering committee on the Google Forms platform and distributed to Arab rheumatologists using social media, WhatsApp, and mass e-mails to evaluate their practice. The mean number of rheumatologists in Arab countries was 0.84 per 100,000 inhabitants (mean age 47.5 years, 55% females), ranging from 0.06 (Sudan) to 1.86 (Tunisia). The number of rheumatologists is expected to increase by 50% in 2032. Nevertheless, a 20% increase in population associated with an increase in demand is also expected. Data from 446 rheumatologists (mean age 43.9 years, 60.5% females) revealed that 72% worked full-time, and 53% were employed in the public sector only. The average waiting time for a rheumatology consultation was 19.9 days. Of 394 rheumatologists, 19% obtained their rheumatology diplomas from non-Arab countries, and 47% of Gulf rheumatologists were non-citizen physicians. Considering local demographic disparities, healthcare system differences, and geographical mobilities, national authorities are advised to implement effective intervention plans to optimize the rheumatology workforce.


  • What is the best referral strategy for axial spondyloarthritis? A prospective multicenter study in patients with suspicious chronic low back pain

    by Nelly Ziade, Avin Maroof, Bassel Elzorkany, Nizar Abdullateef, Asal Adnan, Ahmed Abogamal, Sahar Saad, Lina El Kibbi, Samar Alemadi, Atheer Ansari, et al.